Shigeru Tanaka

Antibody responses to BNT162b2 mRNA COVID-19 vaccine and their predictors among healthcare workers in a tertiary referral hospital in Japan

Takahiro Kageyama, Kei Ikeda, Shigeru Tanaka et al. · Clinical Microbiology and Infection · 2021 · 137 citations · Full text

Vaccination, Vaccine Development, Tertiary Referral Hospital +9

Prediction of Relapse After Discontinuation of Biologic Agents by Ultrasonographic Assessment in Patients With Rheumatoid Arthritis in Clinical Remission: High Predictive Values of Total Gray‐Scale and Power Doppler Scores That Represent Residual Synovial Inflammation Before Discontinuation

Taro Iwamoto, Kei Ikeda, Junichi Hosokawa et al. · Arthritis Care & Research · 2014 · 116 citations

Sox5 and c-Maf cooperatively induce Th17 cell differentiation via RORγt induction as downstream targets of Stat3

Shigeru Tanaka, Akira Suto, Taro Iwamoto et al. · The Journal of Experimental Medicine · 2014 · 114 citations · Full text

T-regulatory Cell, Immunology, Immune Regulation +24

Helios Enhances Treg Cell Function in Cooperation With FoxP3

Hiroaki Takatori, Hirotoshi Kawashima, Ayako Matsuki et al. · Arthritis & Rheumatology · 2015 · 101 citations

[18F]FDG uptake in proximal muscles assessed by PET/CT reflects both global and local muscular inflammation and provides useful information in the management of patients with polymyositis/dermatomyositis

Shigeru Tanaka, Kei Ikeda, Katsuhiro Uchiyama et al. · Lara D. Veeken · 2013 · 96 citations · Full text